UCFI CN Healthy Food Tech Group Corp.
Food and Kindred Products · Nasdaq · SEC CIK 1901203 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.3%
TTM net income YoY-56.3%
TTM EPS YoY-61.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin72.7%
Operating margin35.4%
Net margin16.0%
FCF margin-65.8%
EBITDA margin37.2%
Returns
ROE19.3%
ROA9.0%
ROIC (approx.)—
Asset turnover0.56x
Leverage & solvency
Liabilities / assets26.8%
Debt / equity0.00x
Current ratio2.90x
Interest coverage19.05x
Cash quality & payout
Operating cash flow / net income-4.05x
Accruals ratio45.4%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $27.76M | $11.35M | — | — |
| Cost of revenue | $9.34M | $3.80M | — | — |
| Gross profit | $18.42M | $7.54M | — | — |
| R&D expense | $133,260 | $6,971 | — | — |
| SG&A expense | $4.26M | $1.01M | — | — |
| Operating income | $11.78M | $5.54M | -$309,018 | -$181,003 |
| Interest expense | -$70,056 | -$13,715 | — | — |
| Pretax income | $12.32M | $5.61M | -$309,018 | -$181,003 |
| Income tax | $3.91M | $1.61M | -$226 | — |
| Net income | $8.41M | $4.00M | -$308,792 | -$181,003 |
| EBITDA | $12.25M | $5.74M | — | — |
| EPS (basic) | 0.17 | 0.08 | — | — |
| EPS (diluted) | 0.17 | 0.08 | — | — |
| Weighted avg. shares (diluted) | 48.86M | 47.69M | — | — |
| Balance sheet | ||||
| Cash & equivalents | $33.01M | $41.43M | $15 | — |
| Receivables | $287 | $845 | — | — |
| Inventory | $956,407 | $1.25M | — | — |
| Current assets | $36.89M | $44.02M | $690,134 | — |
| PP&E, net | $4.61M | $4.04M | — | — |
| Intangibles | $83,728 | $49,286 | — | — |
| Total assets | $44.73M | $50.75M | $69.69M | $671,667 |
| Current liabilities | $24.61M | $39.94M | $861,640 | $847,041 |
| Total liabilities | $24.85M | $39.94M | $3.38M | $847,041 |
| Shareholders' equity | $19.87M | $10.81M | $1 | -$175,374 |
| Shares outstanding | 52.23M | 47.69M | 2.00M | 1.93M |
| Cash flow statement | ||||
| Operating cash flow | -$9.04M | $42.12M | -$83,200 | — |
| Capital expenditure | $710,636 | $1,811 | — | — |
| Free cash flow | -$9.76M | $42.11M | — | — |
| Investing cash flow | -$892,352 | -$52,408 | -$69.00M | — |
| Financing cash flow | $2,762 | $582,869 | $69.74M | — |
| Depreciation & amortization | $468,162 | $194,602 | — | — |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.